Oakbrook Investments LLC boosted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 10.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 46,855 shares of the healthcare conglomerate’s stock after buying an additional 4,305 shares during the period. Oakbrook Investments LLC’s holdings in UnitedHealth Group were worth $10,330,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Blue Chip Partners Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $110,000. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its stake in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the last quarter. BDO Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $121,000. Finally, Acrospire Investment Management LLC lifted its stake in shares of UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the last quarter. 85.65% of the stock is currently owned by institutional investors.
Shares of UnitedHealth Group Inc (NYSE:UNH) opened at $227.09 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 1-year low of $160.69 and a 1-year high of $250.79. The firm has a market capitalization of $219,750.00, a PE ratio of 23.90, a price-to-earnings-growth ratio of 1.32 and a beta of 0.70.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.32%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.58%.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now owns 195,314 shares in the company, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 53,396 shares of company stock worth $12,262,067. 0.89% of the stock is owned by company insiders.
UNH has been the topic of several recent analyst reports. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target on the stock in a research note on Saturday, January 20th. Goldman Sachs Group initiated coverage on UnitedHealth Group in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price target on the stock. Credit Suisse Group upped their price target on UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a research note on Wednesday, January 17th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $235.00 price target on shares of UnitedHealth Group in a research note on Monday, December 25th. Finally, Piper Jaffray Companies upped their price target on UnitedHealth Group to $242.00 and gave the company an “overweight” rating in a research note on Wednesday, November 29th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $243.22.
TRADEMARK VIOLATION WARNING: “Oakbrook Investments LLC Buys 4,305 Shares of UnitedHealth Group Inc (UNH)” was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://stocknewstimes.com/2018/02/23/oakbrook-investments-llc-buys-4305-shares-of-unitedhealth-group-inc-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.